An analysis of the clinical significance of the TKI-resistant gene ZNF687 for hepatocellular carcinoma patients
ZNF687 represents a TKI-resistant and growth-dependent gene for HCC, the overexpression of which indicates poor OS for HCC patients. Additionally, ZNF687 is expected to be a druggable target for overcoming TKI resistance, and chaetocin may be a candidate therapeutic compound for ZNF687.
Authors
- Xuan-Fei Wang
- Rong‐Quan He (ORCID: https://orcid.org/0000-0002-7752-2080)
- Guan-Lan Zhang
- Jian‐Di Li (ORCID: https://orcid.org/0000-0001-7050-371X)
- Zhi‐Guang Huang (ORCID: https://orcid.org/0000-0003-4457-9491)
- Gang Chen (ORCID: https://orcid.org/0000-0002-9989-2381)
- Hong Zhao (ORCID: https://orcid.org/0000-0002-5253-6638)
- Songyang Zhong
- Feifei Wu (ORCID: https://orcid.org/0000-0003-1384-3624)
- Kun‐Jun Wu
- Ying-Yu Mo
- Yi-Si Qin
- Jifeng He
Institutions
- Guangxi Medical University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2024-10-02
- DOI
- https://doi.org/10.17219/acem/188425
- Primary Topic
- Chemical Synthesis and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangxi Medical University